Cell Proliferation Assays
Field of Application
Cellular proliferation assays are widely used and accepted in oncology as an initial screen in the transition phase from biochemical screens to biological relevant models. ProQinase's CL40-ProliFiler and CL100-ProliFiler are standardized service packages comprising IC50 determination of one test compound against a defined panel of 40 or 100 cell lines. In addition, ProQinase offers free choice cell proliferation assay services with definition of the number of test cpds and cell lines according to your requirements.
Our Service
CL40-ProliFiler
CL100-ProliFiler
Free Choice Cell Proliferation Assays
# | Cell | Entity of Origin |
|---|---|---|
1 | J82 | Bladder |
2 | HL-60 | Blood/Leukemia |
3 | K562 | Blood/Leukemia |
4 | KARPAS 299 | Blood/Leukemia |
5 | KG1 | Blood/Leukemia |
6 | KG1a | Blood/Leukemia |
7 | KMS-12-BM | Blood/Leukemia |
8 | LP-1 | Blood/Leukemia |
9 | M07e | Blood/Leukemia |
10 | Molm-13 | Blood/Leukemia |
11 | MOLT4 | Blood/Leukemia |
12 | MV4-11 | Blood/Leukemia |
13 | NALM-6 | Blood/Leukemia |
14 | OCI-AML5 | Blood/Leukemia |
15 | OPM-2 | Blood/Leukemia |
16 | P31/FUJ | Blood/Leukemia |
17 | RPMI 8226 | Blood/Leukemia |
18 | RS4 11 | Blood/Leukemia |
19 | SU-DHL5 | Blood/Leukemia |
20 | U-266 | Blood/Leukemia |
21 | U-937 | Blood/Leukemia |
22 | WSU-NHL | Blood/Leukemia |
23 | Saos-2 EC | Bone |
24 | SJSA-1 | Bone |
25 | SK-ES-1 | Bone |
26 | U2OS | Bone |
27 | A172 | Brain |
28 | H4 | Brain |
29 | LN229 | Brain |
30 | SK-N-FI | Brain |
31 | SK-N-MC | Brain |
32 | SK-N-SH | Brain |
33 | U87MG | Brain |
34 | U118MG | Brain |
35 | BT-20 | Breast |
36 | HCC 1569 | Breast |
37 | HCC38 | Breast |
38 | JIMT-1 | Breast |
39 | MCF-7 | Breast |
40 | MDA MB 231 | Breast |
41 | MDA MB 468 | Breast |
42 | SK.BR-3 | Breast |
43 | T47D | Breast |
44 | ZR-75-1 | Breast |
45 | HCC202 | Breast |
46 | EFM-192A | breast |
47 | C33a | Cervix |
48 | HeLa | Cervix |
49 | SiHa | Cervix |
50 | Colo 205 | Colon |
51 | CX-1 | Colon |
52 | DLD-1 | Colon |
53 | HCT116 | Colon |
54 | HCT-15 | Colon |
55 | HT-29 | Colon |
56 | LOVO | Colon |
57 | LS174T | Colon |
58 | RKO | Colon |
59 | SW480 | Colon |
60 | SW620 | Colon |
61 | SW948 | Colon |
62 | T-84 | Colon |
63 | Caco-2 | Colon |
64 | Colo-320DM | Colon |
65 | Hutu 80 | Duodenum |
66 | HEC-1-B | Endometrium |
67 | Ichikawa | Endometrium |
68 | HEC-1-A | endometrium |
69 | HT-1080 | Fibrosarcoma |
70 | A498 | Kidney |
71 | Caki-1 | Kidney |
72 | Caki-2 | Kidney |
73 | HepG2 | Liver |
74 | Hep3B2.1-7 | Liver |
75 | A427 | Lung |
76 | A549 | Lung |
77 | Calu-6 | Lung |
78 | DV90 | Lung |
79 | H1299 | Lung |
80 | H460 | Lung |
81 | HCC827 | Lung |
82 | N417 | Lung |
83 | NCI-H1048 | Lung |
84 | NCI-H1437 | Lung |
85 | NCI-H1581 | Lung |
86 | NCI-H1703 | Lung |
87 | NCI-H2110 | Lung |
88 | NCI-H2286 | Lung |
89 | NCI-H292 | Lung |
90 | NCI-H441 | Lung |
91 | NCI-H838 | Lung |
92 | RERF-LC-MS | Lung |
93 | SCLC-21H | Lung |
94 | SK-LU-1 | Lung |
95 | BEN | lung |
96 | COR-L279 | lung |
97 | EPLC-272H | lung |
98 | LOU-NH91 | lung |
99 | NCI-H1563 | lung |
100 | NCI-H1573 | lung |
101 | NCI-H1838 | lung |
102 | NCI-H2009 | lung |
103 | RERF-LC-Ad2 | lung |
104 | COV434 | Ovary |
105 | EFO-27 | Ovary |
106 | MCAS | Ovary |
107 | NCI-ADR | Ovary |
108 | OV56 | Ovary |
109 | OVCAR-3 | Ovary |
110 | OVK18 | Ovary |
111 | RL95-2 | Ovary |
112 | SK-OV3 | Ovary |
113 | SNU840 | Ovary |
114 | AsPC-1 | Pancreas |
115 | BxPC3 | Pancreas |
116 | Mia PaCA2 | Pancreas |
117 | PANC-1 | Pancreas |
118 | DU-145 | Prostate |
119 | LnCap | Prostate |
120 | PC3 | Prostate |
121 | A2058 | Skin |
122 | A375 | Skin |
123 | A431 | Skin |
124 | MDA MB 435 | Skin |
125 | SK-MEL-3 | Skin |
126 | Hs 746T | Stomach |
127 | MKN-1 | Stomach |
128 | MKN-45 | Stomach |
129 | NCI-N87 | Stomach |
130 | SCH | Stomach |
131 | SNU-1 | Stomach |
Infos in Brief
-
CL40-ProliFiler Slots 2018
-
Testing will start on: September 03 // October 01 // November 05 // December 03
-
CL100-ProliFiler Slots 2018
-
Testing will start on: February 26 // June 04 // September 03 // November 26
-
Cpd Exposure
-
72 h
-
Readout
-
CellTiter-Glo® Luminescent
-
Testing Formats
-
IC50 (8 semi-log dilutions in duplicate)
-
Cpd Submission
-
Solved or as pre-weighed powder
-
Tolerable Solvent
-
Max 0.1 % DMSO
-
Reference Cpd
-
included (known proteasome inhibitor)
-
Report
-
Comprehensive evaluation of data including raw data for own analysis
-
Related Publication from ProQinase
-
Summary Sheet
-
List of Cell Lines for this Services
-
Guidelines for Cpd Submission